相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacy in the acute treatment of migraine
Peer Tfelt-Hansen et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Effects of a Supratherapeutic Dose of Investigational Orally Inhaled Dihydroergotamine (MAP0004) on QT Interval: A Randomized, Double-Blind, Active- and Placebo-Controlled Crossover Study in Healthy Volunteers
Shashidhar Kori et al.
CLINICAL THERAPEUTICS (2012)
MAP0004: dihydroergotamine mesylate inhalation aerosol for acute treatment of migraine
Stephen Silberstein
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Acute Treatment of Migraine: Established and Emerging Therapies
Alan M. Rapoport
HEADACHE (2012)
Dihydroergotamine, Ergotamine, Methysergide and Sumatriptan - Basic Science in Relation to Migraine Treatment
Carl Dahlof et al.
HEADACHE (2012)
MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine
Sheena K. Aurora et al.
HEADACHE (2011)
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action
Georges Vauquelin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Current practice and future directions in the prevention and acute management of migraine
Peter J. Goadsby et al.
LANCET NEUROLOGY (2010)
A Randomized, Double Blind, Placebo-Controlled Study of MAP0004 in Adult Patients With Migraine
Sheena K. Aurora et al.
HEADACHE (2009)
Safety and pharmacokinetics of dihydroergotamine mesylate administered via a novel (Tempo™) Inhaler
Stephen B. Shrewsbury et al.
HEADACHE (2008)
DHE in the pharmacotherapy of migraine: Potential for a larger role
Joel R. Saper et al.
HEADACHE (2006)
Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine
Joel R. Saper et al.
HEADACHE (2006)
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
JNJM de Hoon et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
A comment on time-to-event analysis for headache relief
P Tfelt-Hansen
CEPHALALGIA (2000)